Oliver Howes

Biographic Data

ID6363179
NAMEOliver Howes
GIVEN NAMESOliver
FAMILY NAMEHowes
SIGNATUREHOWES O
AFFILIATIONSKing's College London
ORCID0000-0002-2928-1972
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2014
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis

    Open AccessDominic Oliver, Cathy Davies et al.ARTICLEFrontiers in Psychiatry2023

    On this evidence, APS and BLIPS are unlikely to be neurobiologically distinct. Due to this and the weak-to-moderate evidence for the null hypothesis, future research should investigate larger samples of APS and BLIPS through collaboration across large-scale international consortia

  • The impact of the prolonged Covid-19 pandemic on stress resilience and mental health

    Open AccessMirko Manchia, Anouk W Gathier et al.ARTICLEEuropean Neuropsychopharmacology2022

    The global public health crisis caused by COVID-19 has lasted longer than many of us would have hoped and expected. With its high uncertainty and limited control, the COVID-19 pandemic has undoubtedly asked a lot from all of us. One important central question is: how resilient have we proved in face of the unprecedented and prolonged coronavirus pandemic? There is a vast and rapidly growing literature that has examined the impact of the pandemic …

  • The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response

    Open AccessUzma Zahid, Robert A Mccutcheon et al.ARTICLEFrontiers in Psychiatry2022

    These findings indicate that treatment response is unlikely to be associated with baseline glutamatergic metabolites prior to antipsychotic treatment, and there is no major effect of antipsychotic treatment on glutamatergic metabolites in the ACC

  • Stress resilience during the coronavirus pandemic

    Open AccessChristiaan H Vinkers, Thérèse van Amelsvoort et al.ARTICLEEuropean Neuropsychopharmacology2020

    The epidemic of the 2019 novel coronavirus SARS-CoV-2, causing the coronavirus disease 2019 (COVID-19) is a global public health emergency with multifaceted severe consequences for people's lives and their mental health. In this article, as members of the European College of Neuropsychopharmacology (ECNP) Resilience, we will discuss the urgent need for a focus on resilience during the current coronavirus pandemic. Resilience is pivotal to cope wi…

  • Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for Psychosis

    Open AccessIlaria Bonoldi, Paul Allen et al.ARTICLEFrontiers in Psychiatry2019

    Introduction: Alterations of the "pre-reflective" sense of first-person perspective (e.g., of the "basic self") are characteristic features of schizophrenic spectrum disorders and are significantly present in the prodromal phase of psychosis and in subjects at ultra-high risk for psychosis (UHR). Studies in healthy controls suggest that neurobiological substrate of the basic self involves cortical midline structures, such as the anterior and post…

  • Magnetic Resonance and Molecular Imaging in Psychiatry

    Open AccessOliver Howes, Oliver D HowesCHAPTERInternational Encyclopedia of the…2015

  • Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation

    Open AccessCelia J A Morgan, Chris Dodds et al.ARTICLEFrontiers in Psychiatry2014

    Ketamine, a non-competitive N-methyl-d-aspartate receptor antagonist, is rising in popularity as a drug of abuse. Preliminary evidence suggests that chronic, heavy ketamine use may have profound effects on spatial memory but the mechanism of these deficits is as yet unclear. This study aimed to examine the neural mechanism by which heavy ketamine use impairs spatial memory processing. In a sample of 11 frequent ketamine users and 15 poly-drug con…